PHARMIMPULSE
Board
1 director, last change in 2021Manager
since 11-08-2015
6-year term from 2021
listed in the 2025 annual accounts, filed on 27-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 28. - Représentation Le(s) gérant(s) de la société représente(nt) celle-ci à l'égard des tiers en justice.”deed of 28-01-2025
Mandates through the years
1 name, the dashed line is todayPaul RANSART
Manager
Manager
BoardRest of the term
Mandates as a list
- Paul RANSART
- Manager, from 11-08-2015 to date
Control
100%
This company
PHARMIMPULSE
Equity -€77,307
Loss €81,057 in 2025
Further up the chainBLUESTONE 51.44%
Capital
- Contribution
- €3,750
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- envergure invest
- PHARMACIE DEFRE
- PALATINE
Source: lists of holdings in the owners' accounts
Articles of association
deed of 28-01-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Totalité ou partie des parts sociales, non-dissolution,parts associé décédé reviennent héritiers légataires avec consentement tous associés”
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Associés à majorité, liquidateurs peuvent exiger paiement associés prorata parts sociales”
Shareholders
3 ownersOwners 3
- PALATINEparentEquity €487,128 Loss of €60,905 in 2025 (loss of €90,665 in 2024) Checked score 51Sourceaccounts PALATINE 2024100%
- Equity €175,559 Profit of €14,981 in 2025 (profit of €58,320 in 2024) Checked score 646.66%
- Equity €353,809 Profit of €72,183 in 2025 (profit of €58,682 in 2024) Checked score 836.66%